Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer Multicenter prospective ...
Copyright: © 2024 The Authors. Published by Elsevier Ltd.
dCentre for Exercise Medicine, Physical Activity and Health, Sports and Exercise Sciences Research Institute, Ulster University, Newtownabbey, UK eSchool of Sport, Exercise and Health Sciences, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results